市場調查報告書
商品編碼
1433410
全球縫合錨固裝置市場 2023-2030Global Suture Anchor Devices Market 2023-2030 |
預計在預測期內(2024-2031年),全球縫合錨釘裝置市場將以 4.3%的CAGR成長。市場成長的重要因素包括骨科損傷盛行率的增加,以及在解決韌帶和其他肌肉骨骼結構相關問題的手術中擴大使用。例如,2021年 12月,英國與工作相關的肌肉骨骼疾病統計報告指出,2020/21年有 47 萬名工人患有與工作相關的肌肉骨骼疾病(新發或長期存在)。每 10 萬名工人中有 1,420 人患有此病,佔所有工作引起的健康不良的 28.0%。
全球縫合錨裝置市場依材料類型、產品、捆紮類型和最終用途細分。根據材料類型,市場分為金屬縫合錨釘、生物可吸收縫合錨釘等。其他包括聚醚醚酮(PEEK)縫合錨釘裝置。根據產品,市場分為可吸收性和不可吸收性。根據打結類型,市場分為有結縫合錨釘和無結縫合錨釘。此外,根據最終用途,市場細分為醫院、診所和門診手術中心。在材料類型中,生物可吸收縫合錨釘細分市場預計將佔據相當大的市場佔有率,因為它降低了不良反應、發炎或排斥的風險,使其適合廣泛的患者。
在捆綁類型中,無結縫合錨定的細分市場預計將在預測期內成長。該細分市場受到骨科和軟組織手術中微創手術日益成長的趨勢的推動,這增加了對無結縫合錨定裝置的需求。無結縫合錨釘消除了手術期間打結的需要,簡化了手術並降低了併發症的風險,並且因其易於使用和縮短手術時間而受到外科醫生的青睞。因此,製造商都致力於推出新產品來滿足市場需求。2020年 9月,醫療技術公司 Smith+Nephew plc 推出了 HEALICOIL(TM)無結縫合錨,擴展了其革命性的肩袖修復先進癒合解決方案系列。該產品組合包括創新的 REGENETEN(TM)生物感應植入物和新型 REGENESORB(TM)材料。 HEALICOIL 無結縫合錨的開放式架構設計與 REGENESORB 材料相結合,目的是促進骨骼癒合和形成的快速啟動。
全球縫合錨定裝置市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於對縫合錨定裝置的需求不斷成長、老年人口不斷增加、微創手術數量不斷增加、政府的支持性舉措和有利的醫療保健政策,預計亞太地區將在預測期內實現成長,推動縫合錨定裝置的成長亞太市場。
由於運動相關損傷和年齡相關骨科疾病的盛行率不斷增加,預計北美將在縫合錨固裝置市場中佔據顯著佔有率。根據《關節鏡、運動醫學和復健》雜誌報道,2022年進行的一項研究顯示,21%的球員經歷過結構性膝關節損傷,總體受傷率為每 1,000 場比賽中 5.4 次受傷。依年齡分層,結構性膝關節損傷率在20歲以下的球員中最高(3.2/1,000 GE),其次是30歲以下(3.1/1,000 GE)、25至29歲(3.0/1,000 GE)和20歲以下至 24年(2.3/100 GE)。以每場比賽分鐘數計算,膝傷發生率最高的是上場時間超過30 分鐘的球員(3.9/1,000 GE),其次是20.0 至29.9 分鐘(3.0/1,000 GE)和10.0 至19.9 分鐘(1.8/1,000 GE)。因此,老年人口的增加與骨科手術的增加有關,推動了該地區研究的市場。2022年4月,加拿大統計局發表文章 《2021年人口普查顯示加拿大85歲以上人口成長概況》,全國65歲以上人口有730萬人。此外,在未來 25年(到2046年),85 歲及以上的人口可能會增加兩倍,達到近 250 萬人。
服務於縫合錨定裝置市場的主要公司包括 Arthrex, Inc.、ConMed Corp.、Johnson and Johnson(DePuy Synthes, Inc.)、Smith & Nephew plc 等。市場參與者透過各種策略(包括併購、夥伴關係、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022年 12月,Stryker Corp. 推出了 Citrefix(TM),這是一種用於足部和踝關節外科手術的縫合錨釘系統。新系統使用了 Citregen(TM),這是一種生物可吸收材料,目的是模仿天然骨骼的化學和結構。
Global Suture Anchor Devices Market Size, Share & Trends Analysis Report by Material Type (Metallic Suture Anchor, Bio-Absorbable Suture Anchor, and Others), by Product (Absorbable, and Non-Absorbable), by Tying Type (Knotted Suture Anchors, and Knotless Suture Anchors), by End-Use (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)
The global suture anchor devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2024-2031). Significant factors attributed to market growth includes increasing prevalence of orthopedic injuries, and growing use in procedures to address issues related to ligaments, and other musculoskeletal structures. For instance, iIn December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.
The global suture anchor devices market is segmented on the by material type, product, tying type, and end-use. Based on the material type, the market is sub-segmented into metallic suture anchor, bio-absorbable suture anchor, and others. Others include polyetheretherketone (PEEK) suture anchor devices. Based on the product, the market is sub-segmented into absorbable, and non-absorbable. Based on the tying type, the market is sub-segmented into knotted suture anchors, and knotless suture anchors. Further, based on end-use, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers. Among the material type, the bio-absorbable suture anchor sub-segment is anticipated to hold a considerable share of the market, owing to the reducing the risk of adverse reactions, inflammation, or rejection, making them suitable for a wide range of patients.
Among the tying type, knotless suture anchors sub-segments expected to grow over the forecast period. The segment is driven by the growing trend towards minimally invasive procedures in orthopedic and soft tissue surgeries contributes to the demand for knotless suture anchor devices. Knotless suture anchors eliminate the need for tying knots during surgery, simplifying the procedure, and reducing the risk of complications, and are preferred by surgeons for their ease of use and potential for faster surgical times. Thus, the manufacturers are emphasizing on launching new products to cater to the demand in the market. In September 2020, Smith+Nephew plc, the medical technology business, launched the HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of advanced healing solutions for rotator cuff repair. This portfolio included the innovative REGENETEN™ Bioinductive Implant and novel REGENESORB™ Material. The open architecture design of the HEALICOIL KNOTLESS Suture Anchor coupled with REGENESORB Material was designed to facilitate a jump start in bone healing and formation.
The global suture anchor devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow over the forecast period, owing to the growing demand for suture anchor devices, increasing geriatric population, growing number of minimally invasive procedures, supportive government initiatives, and favorable healthcare policies, driving the suture anchor devices market in the Asia-Pacific.
North America is expected to hold a prominent share in the suture anchor devices market, owing to the increasing prevalence of sports-related injuries and age-related orthopedic conditions. As reported in the Arthroscopy, Sports Medicine, and Rehabilitation journal, a study conducted in 2022 revealed that 21% of players experienced structural knee injuries, with an overall injury rate of 5.4 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.2/1,000 GE) followed by less than 30 years old (3.1/1,000 GE), 25 to 29 years (3.0/1,000 GE), and 20 to 24 years (2.3/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.9/1,000 GE), followed by 20.0 to 29.9 minutes (3.0/1,000 GE), and 10.0 to 19.9 minutes (1.8/1,000 GE). Thus, an increasing geriatric population is associated with an increase in orthopedic surgeries, thus boosting the market studied in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Furthermore, over the next 25 years (by 2046), the population aged 85 and above may get triple to almost 2.5 million people.
The major companies serving the suture anchor devices market include Arthrex, Inc., ConMed Corp., Johnson and Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, Stryker Corp., launched the Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system used Citregen™, a bioresorbable material designed to mimic the chemistry and structure of native bone.